Oldenlandia diffusa Ameliorates on Atopic Dermatitis in Mice
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Oldenlandia diffusa (OD), a member of the Rubiaceae family, has been used for treating inflammatory and infectious diseases. However, the anti-atopic effects of OD are not completely understood yet. Thus, the aim of the present study was to elucidate beneficial effects of OD on atopic dermatitis (AD) in vivo. We examined the pharmacological effects of OD on compound 48/80- or histamine-induced scratching behaviors and 2, 4-dinitrochlrobenzene (DNCB)-induced AD-like skin lesions in mice. Additionally, we evaluated regulatory effects of OD on the expression of interleukin (IL)-6 and tumor necrosis factor (TNF)–α in DNCB-induced AD-like skin lesions. Results showed that OD inhibited the scratching behavior and AD symptoms. It also decreased serum levels of IgE and histamine in mice. Moreover, OD significantly ameliorated the expression of IL-6 and TNF–α in AD-like skin lesion. These finding suggest experimental evidence of that OD’s potential for treating AD.
Abstract
Oldenlandia diffusa (OD), a member of the Rubiaceae family, has been used for treating inflammatory and infectious diseases. However, the anti-atopic effects of OD are not completely understood yet. Thus, the aim of the present study was to elucidate beneficial effects of OD on atopic dermatitis (AD) in vivo. We examined the pharmacological effects of OD on compound 48/80- or histamine-induced scratching behaviors and 2, 4-dinitrochlrobenzene (DNCB)-induced AD-like skin lesions in mice. Additionally, we evaluated regulatory effects of OD on the expression of interleukin (IL)-6 and tumor necrosis factor (TNF)–α in DNCB-induced AD-like skin lesions. Results showed that OD inhibited the scratching behavior and AD symptoms. It also decreased serum levels of IgE and histamine in mice. Moreover, OD significantly ameliorated the expression of IL-6 and TNF–α in AD-like skin lesion. These finding suggest experimental evidence of that OD’s potential for treating AD.
참고문헌 (23)
- Allam, J. P., "The pathophysiology of atopic eczema", Clin. Exp. Dermatol, 31, pp.89~93 (2006)
- Berke, R., "Atopic dermatitis : an overview", Am. Fam. Physician, 86, pp.35~42 (2012)
- Bieber, T, "Atopic dermatitis", N. Engl. J. Med, 358, pp.1483~1494 (2008)
- Buske-Kirschbaum, A., "Psychobiological aspects of atopic dermatitis : an overview", Psychother. Psychosom, 70, pp.6~16 (2001)
- Caughey, G, H, "Mast cell proteases as pharmacological targets", Eur. J. Pharmacol, 778, pp.44~55 (2016)
- Fedenko, E. S., "Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals", Self Nonself, 2, pp.120~124 (2011)
- Gupta, S., "Anticancer activities of Oldenlandia diffusa", J. Herb. Pharmacother, 4, pp.21~33 (2004)
- Jemima, E. A., "Functional characterization of histamine H4 receptor on human mast cells", Mol. Immunol, 62, pp.19~28 (2014)
- Jeon, W. J., "Salvianolic acid A suppresses DNCB-induced atopic dermatitis-like symptoms in BALB", c mice, 2021, pp.2021, 7902592~
- Kang, D.G, "Target identification of Oldenlandia diffusa extract for anticancer property", Curr. Dev. Nutr, 5, pp.329~ (2021)
- Kee, J. Y., "Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via mitogenactivated protein kinase signaling pathway", J. Ginseng Res, 43, pp.282~290 (2019)
- Kim, S. J., "Oldenlandia diffusa ameliorates dextran sulphate sodiuminduced colitis through inhibition of NF-κB activation", Am. J. Chin. Med, 39, pp.957~969 (2011)
- Leung, D. Y., "New insights into atopic dermatitis", J. Clin. Investig, 113, pp.651~657 (2004)
- Minami, K., "A chronic model for evaluating the itching associated with allergic conjunctivitis in rats", Int. Immunopharmacol, 4, pp.101~108 (2004)
- 명노일, "Adenophorae Radix Attenuates Mast Cell-mediated Allergic Inflammation through Down-regulation of NF-κB", Caspase-1 Activation, 2020, pp.33(6), 659~665[DOI]
- Ogata, H., "Cytokine and anti-cytokine therapies for inflammatory bowel disease", Curr. Pharm. Des, 9, pp.1107~1113 (2003)
- Ovesna, Z, "Pentacyclic triterpenoic acids : new chemoprotective compounds", Minireview. Neoplasma, 51, pp.327~333 (2004)
- Park, G., "Coriander alleviates 2,4-dinitrochlorobenzeneinduced contact dermatitis-like skin lesions in mice", J. Med. Food, 7, pp.862~868 (2014)
- Saeki, H., "Guidelines for management of atopic dermatitis", J. Dermatol, 36, pp.563~577 (2009)
- Sugimoto, M., "Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC", Ngamice, 2006, pp.15, 875~882
- Trefzer, U., "Cytokine and anticytokine therapy in dermatology", Expert. Opin. Biol. Ther, 3, pp.733~743 (2003)
- Vestergaard, C., "A Th2chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+lymphocytes into lesional atopic dermatitis skin", J. Invest. Dermatol, 115, pp.640~646 (2000)
- Wajima, T., "Oldenlandia diffusa extract inhibits biofilm formation by haemophilus influenzae clinical isolates", PLoS One, 10, pp.1371~ (2016)
